The privilege of COVID-19 vaccine wastage - Hong Kong

Joshua Yeuk Shun Tran1, Phoebe Chi Fei Chan2, Samuel Yeung-Shan Wong3

  • 1Faculty of Medicine The Chinese University of Hong Kong Hong Kong SAR China.

PubMed

Insights

Hong Kong faced suboptimal COVID-19 vaccine uptake despite ample supply, leading to significant vaccine wastage. Addressing public hesitancy and logistical issues is crucial to prevent future waste.

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • Hong Kong experienced diverse COVID-19 impacts, from strict restrictions to high caseloads.
  • Despite privileged access to vaccines, uptake remained below 55% six months post-introduction.
  • Factors like perceived risks, distrust, and logistical challenges contributed to vaccine hesitancy.

Purpose of the Study:

  • To analyze the causes of suboptimal COVID-19 vaccine uptake in Hong Kong.
  • To investigate the extent and reasons for vaccine wastage.
  • To recommend strategies for improving vaccine uptake and management.

Main Methods:

  • Analysis of vaccine procurement and uptake data.
  • Review of factors influencing public vaccine hesitancy.
  • Assessment of logistical challenges and vaccine wastage.

Main Results:

  • Less than 55% of Hong Kong's population vaccinated within six months.
  • Significant vaccine wastage, potentially up to 2 million doses, due to hesitancy and logistical issues.
  • Vaccine nationalism identified as a contributing factor to inequity and wastage.

Conclusions:

  • Urgent interventions are needed to address COVID-19 vaccine hesitancy in Hong Kong.
  • Improved logistical management is essential to prevent substantial vaccine wastage.
  • Addressing vaccine inequity and promoting uptake are critical for public health resilience.